Systemic fungal infection in a dog: a unique case in Ireland

Irish Veterinary Journal

Carmel T Mooney²  Hester McAllister⁴  Bernadette Leggett³  Stratos Papakonstantinou¹  Sabela Atencia² 

[1] Biobest Laboratories Ltd. 6 Charles Darwin House, The Edinburgh Technopole, Milton Bridge, Nr Penicuik EH26 0PY, Scotland;Department of Small Animal Clinical Studies, University Veterinary Hospital, University College Dublin, Belfield, Dublin Dublin 4, Ireland;Department of Microbiology, University Veterinary Hospital, University College Dublin, Belfield, Dublin Dublin 4, Ireland;Department of Diagnostic Imaging, University Veterinary Hospital, University College Dublin, Belfield, Dublin Dublin 4, Ireland

关键词: Ciclosporin;    Systemic infection;    Dog;    Fungus;   

Others  :  1135874
DOI  :  10.1186/2046-0481-67-17

 received in 2014-02-02, accepted in 2014-07-21,  发布年份 2014

【 摘 要 】

A three year old male entire Staffordshire bull terrier was referred to University College Dublin Veterinary Hospital, with a two week history of fever, inflammation of the right hock, lameness on the right hindlimb, peripheral lymphadenopathy and gastrointestinal signs (vomiting and diarrhoea). For the preceding three months the dog had been treated for atopic dermatitis with oral ciclosporin (5 mg/kg, PO, q 24 hours).

Cytological analysis of the affected lymph nodes demonstrated fungal-like organisms predominantly contained within macrophages. Subsequent fungal culture and microscopic identification confirmed the presence of a Byssochlamys sp. This fungus is a saprophytic organism which has been associated with mycotoxin production. It has not previously been identified as a cause of systemic infection in animals or humans.

Ciclosporin was discontinued, and a second generation triazole, voriconazole prescribed at a dose of 6 mg/kg for the first two doses, and continued at 3 mg/kg every 12 hours for six months. There was an excellent response. Follow-up examination five weeks after treatment was completed confirmed remission of the disease. The dog remains alive and well three years later.

The present case represents an unusual fungal infection in a dog secondary to immunosuppressive therapy with ciclosporin. Such a possibility should be considered in animals presenting with signs consistent with systemic infection when receiving immunosuppressive medication.

【 授权许可】

   
2014 Atencia et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Peterson AL, Torres SM, Rendahl A, Koch SN: Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study. Vet Dermatol 2012, 23:201-243.
• [2]Salisbury MA, Kaswan RL, Brown J: Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca. Am J Vet Res 1995, 56:880-884.
• [3]Schultz RM, Johnson EG, Wisner ER, Brown NA, Byrne BA, Sykes JE: Clinicopathologic and Diagnostic Imaging Characteristics of Systemic Aspergillosis in 30 Dogs. J Vet Intern Med 2008, 22:851-859.
• [4]Barrs VR, Martin P, Beatty JA: Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J 2006, 84:30-35.
• [5]Fry DR, McSporran KD, Ellis JT, Harvey C: Protozoal Hepatitis Associated with Immunosuppressive Therapy in a Dog. J Vet Intern Med 2009, 23:366-368.
• [6]Blackwood L, German A, Stell A, O’Neill T: Multicentric lymphoma in a dog after cyclosporine therapy. J Small Anim Pract 2004, 45:259-262.
• [7]Callan MB, Preziosi D, Mauldin E: Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine. Vet Dermatol 2005, 16:338-345.
• [8]Murphy K, Malik R, Barnes A, Hotston-Moore A, Pearson G, Barr F: Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog. Vet Rec 2011, 168:217.
• [9]Day MJ, Penhale WJ, Habay MJ, Robinson WF, Huxtable CRR, Eger CE, Shaw SE, Mills JN, Wyburn RS: Disseminated aspergillosis in dogs. Aust Vet J 1986, 63:55-59.
• [10]Ettinger SJ: Textbook of Veterinary Internal Medicine. In Histoplasmosis, Blastomicosis, Sporotrichosis, Candidiasis, Pythiosis, and Lagenidiosis. Volume1 7th edition. Edited by Ettinger SJ, Feldman EC. 2010, 971-988.
• [11]Maddison JE, Page SW, Church D: Small Animal Clinical Pharmacology. Elsevier Health Sciences 2nd edition. 2008, 272-275.
• [12]Archer TM, Boothe DM, Langston VC, Fellman CL, Lunsford KV, Mackin AJ: Oral cyclosporine treatment in dogs: a review of the literature. J Vet Intern Med 2014, 28:1.
• [13]Maddison JE, Page SW, Church D: Small Animal Clinical Pharmacology. Elsevier Health Sciences 2008, 193.
• [14]Lees GE, Brown SA, Elliott J, Grauer GF, Vaden SL: Assessment and management of Proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J Small Animal Int Med 2005, 19:377-385.
• [15]Grauer GF: Measurement, interpretation, and implications of Proteinuria and Albuminuria. Vet Clin N Am Small Anim Pract 2007, 37:283-295.